Rostafuroxin
Rostafuroxin (PST 2238) is a research compound investigated for the treatment of essential hypertension. It functions as a selective antagonist of the endogenous ouabain receptor, with studies demonstrating its antihypertensive effects in both in vitro assays and in vivo animal models.
Product Specifications
CAS Number
156722-18-8
Product Name Alternative
Digitoxigenin, antihypertensive, ATP1A1, inhibit, Ouabain, Na+/K+ ATPase, Na+/K+-ATPase, Inhibitor, EGFR, RSV-GFP, RSV, Rostafuroxin, Respiratory syncytial virus, Sodium potassium pump, Tyr845, PST 2238, PST2238, PST-2238, phosphorylation
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
98.24% (May vary between batches)
Solubility
DMSO:50 mg/mL (133.51 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.34 mM)
Smiles
C[C@]12CC[C@H]3[C@@H] (CC[C@@H]4CC (O) CC[C@]34C) [C@]1 (O) CCC2 (O) c1ccoc1
Molecular Formula
C23H34O4
Molecular Weight
374.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
